NCT03033303 2025-10-07A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk NeuroblastomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed59 enrolled